Doubled haploidy

Yield10 Bioscience Announces Start of Field Tests of Winter Camelina Varieties

Retrieved on: 
Wednesday, October 28, 2020

WOBURN, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties.

Key Points: 
  • WOBURN, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it has begun field testing to evaluate the emergence and agronomics of winter Camelina sativa varieties.
  • Having previously evaluated the Camelina sativa winter varieties in 2019/2020 , Yield10 continues to pursue commercial efforts to leverage its technology in the potential high growth cash cover crop market.
  • The objectives of the study are to determine the seed and oil yield potential of winter Camelina varieties, and to scale up certain plant lines to support conducting larger studies.
  • The field tests will evaluate the best performing wild-type and doubled haploid lines from the 2019/2020 winter season.

Yield10 Bioscience Announces Successful Evaluation of Emergence and Establishment in Field Tests of Winter Camelina Varieties

Retrieved on: 
Tuesday, August 4, 2020

WOBURN, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it conducted field testing during the 2019/2020 winter season to evaluate emergence of winter Camelina sativa varieties.

Key Points: 
  • WOBURN, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it conducted field testing during the 2019/2020 winter season to evaluate emergence of winter Camelina sativa varieties.
  • Two wild-type and two double haploid winter Camelina lines developed in-house by Yield10s Canadian subsidiary, Metabolix Oilseeds, were studied in the field test.
  • Our team has developed new double haploid winter Camelina varieties which performed very well in our winter field trial under the extreme winter conditions encountered in Saskatchewan, said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience.
  • As development of our novel performance traits progresses, we envision deploying our traits in double haploid varieties of both winter and spring Camelina.